Posts With Tag NASDAQ ANEB

Showing 1 - 2 of 2 Posts

Anebulo Pharmaceuticals 8-K Report: Key Insights from February 20, 2025 Filing

•

Form 8-K

•

2025-02-24

Last updated: about 1 month ago

Anebulo Pharmaceuticals 8-K Report: Key Insights from February 20, 2025 Filing

Discover the latest financial disclosures from Anebulo Pharmaceuticals, Inc. in their 8-K report, filed February 20, 2025. Key metrics and compliance insights included.

Anebulo Pharmaceuticals biotechnology financial reporting NASDAQ ANEB XBRL compliance

Anebulo Pharmaceuticals 8-K Report: Key Updates & Insights for Investors

•

Form 8-K

•

2024-12-23

Last updated: 4 months ago

Anebulo Pharmaceuticals 8-K Report: Key Updates & Insights for Investors

Discover essential insights from Anebulo Pharmaceuticals' 8-K report filed on December 22, 2024. Stay informed about stock performance, financial updates, and key company changes.

Anebulo Pharmaceuticals biotechnology NASDAQ ANEB financial reporting 8-K filing